Revolution Medicines Inc [NASDAQ: RVMD] closed the trading session at $43.92.
The stocks have a year to date performance of 53.14 percent and weekly performance of 13.17 percent. The stock has been moved at 54.76 percent over the last six months. The stock has performed 9.39 percent around the most recent 30 days and changed 37.64 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 1.32M shares, RVMD reached to a volume of 4218416 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Revolution Medicines Inc [RVMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVMD shares is $46.29 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVMD stock is a recommendation set at 1.07. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Revolution Medicines Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 08, 2024. While these analysts kept the previous recommendation, Needham raised their target price from $36 to $46. The new note on the price target was released on April 12, 2024, representing the official price target for Revolution Medicines Inc stock. Previously, the target price had yet another raise from $36 to $48, while Raymond James kept a Strong Buy rating on RVMD stock.
The Average True Range (ATR) for Revolution Medicines Inc is set at 1.67, with the Price to Sales ratio for RVMD stock in the period of the last 12 months amounting to 1585.64. The Price to Book ratio for the last quarter was 4.20, with the Price to Cash per share for the same quarter was set at 10.33.
RVMD stock trade performance evaluation
Revolution Medicines Inc [RVMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.17. With this latest performance, RVMD shares gained by 9.39% in over the last four-week period, additionally plugging by 54.76% over the last 6 months – not to mention a rise of 66.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RVMD stock in for the last two-week period is set at 71.04, with the RSI for the last a single of trading hit 77.40, and the three-weeks RSI is set at 67.03 for Revolution Medicines Inc [RVMD]. The present Moving Average for the last 50 days of trading for this stock 38.71, while it was recorded at 39.07 for the last single week of trading, and 30.57 for the last 200 days.
Revolution Medicines Inc [RVMD]: An insightful look at the core fundamentals
Revolution Medicines Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 18.45 and a Current Ratio set at 18.45.
Revolution Medicines Inc [RVMD]: Institutional Ownership
The top three institutional holders of RVMD stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in RVMD stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in RVMD stock with ownership which is approximately 5.1238%.
